AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F1299-F1307, 2007. First published August 8, 2007; doi:10.1152/ajprenal.00293.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/F1299    most recent
00293.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, Y.
Right arrow Articles by Wang, W.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, Y.
Right arrow Articles by Wang, W.-H.

PGE2 inhibits apical K channels in the CCD through activation of the MAPK pathway

Yan Jin,1,2,* Zhijian Wang,2,* Yan Zhang,2 Baofeng Yang,1 and Wen-Hui Wang2

1Department of Pharmacology, Harbin Medical University, Harbin, China; and 2Department of Pharmacology, New York Medical College, Valhalla, New York

Submitted 26 June 2007 ; accepted in final form 26 July 2007

We used the patch-clamp technique and Western blot analysis to explore the effect of PGE2 on ROMK-like small-conductance K (SK) channels and Ca2+-activated big-conductance K channels (BK) in the cortical collecting duct (CCD). Application of 10 µM PGE2 inhibited SK and BK channels in the CCD. Moreover, either inhibition of PKC or blocking mitogen-activated protein kinase (MAPK), P38 and ERK, abolished the effect of PGE2 on SK channels in the CCD. The effect of PGE2 on SK channels was completely blocked in the presence of SC-51089, a specific EP1 receptor antagonist, and mimicked by application of sulprostone, an agonist for EP1 and EP3 receptors. To determine whether PGE2 stimulates the phosphorylation of P38 and ERK, we treated mouse CCD cells (M-1) with PGE2. Application of PGE2 significantly stimulated the phosphorylation of P38 and ERK within 5 min. The dose-response curve of PGE2 effect shows that 1, 5, and 10 µM PGE2 increased the phosphorylation of P38 and ERK by 20–21, 50–80, and 80–100%, respectively. The stimulatory effect of PGE2 on MAPK phosphorylation was not affected by indomethacin but abolished by inhibition of PKC. This suggests that the effect of PGE2 on MAPK phosphorylation is PKC dependent. Also, the expression of cyclooxygenase II and PGE2 concentration in renal cortex and outer medulla was significantly higher in rats fed a K-deficient diet than those on a normal-K diet. We conclude that PGE2 inhibits SK and BK channels and that there is an effect of PGE2 on SK channels in the CCD through activation of EP1 receptor and MAPK pathways. Also, high concentrations of PGE2 induced by K restriction may be partially responsible for increasing MAPK activity during K restriction.

cyclooxygenase; arachidonic acid; P38; ERK; ROMK; renal K secretion



Address for reprint requests and other correspondence: W.-H. Wang, Dept. of Pharmacology, New York Medical Univ., Valhalla, NY 10595 (e-mail: wenhui_wang{at}nymc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.